Streetbeat News

Earnings

TIVC

TTOO

During Thursday's pre-market session, several healthcare stocks experienced significant movement. Tivic Health Systems, Advanced Health, Pliant Therapeutics, Modular Medical, Infinity Pharmaceuticals, and Shuttle Pharmaceuticals saw increases, with Tivic Health Systems leading with a 47.2% increase. On the other hand, T2 Biosystems, Novo Integrated Sciences, Strata Skin Sciences, Kronos Bio, Calliditas Therapeutics, and Aclarion experienced decreases, with T2 Biosystems leading the losses with a 24.4% decrease.

Portfolio Pulse from Benzinga Insights

August 17, 2023 | 1:06 pm

KULR

RCRT

SLND

SRFM

Several industrial stocks experienced significant movement in Thursday's pre-market session. Southland Holdings, Recruiter.Com Group, Knightscope, Pineapple Energy, American Rebel Holdings, and Ocean Power Techs saw gains, while KULR Tech Gr, Surf Air Mobility, Asure Software, Alight, DSS, and Highway Holdings experienced losses.

Portfolio Pulse from Benzinga Insights

August 17, 2023 | 1:06 pm

DBGI

Digital Brands Group (NASDAQ:DBGI) reported Q2 earnings of $0.38 per share, a 103.8% increase YoY. The company also reported $4.49 million in sales, a 20.18% increase YoY.

Portfolio Pulse from Benzinga Newsdesk

August 17, 2023 | 1:03 pm

HR

PI

TSVT

Insider trading has been observed in three healthcare stocks: Impinj, Inc. (PI), 2seventy bio, Inc. (TSVT), and Healthcare Realty Trust Incorporated (HR). Impinj and Healthcare Realty Trust posted upbeat Q2 results, while 2seventy bio reported a narrower Q2 loss. The insiders' purchases may indicate confidence in the companies' prospects.

Portfolio Pulse from Lisa Levin

August 17, 2023 | 1:02 pm

SNPS

Synopsys, Inc. (NASDAQ:SNPS) reported better-than-expected Q3 results with earnings of $2.88 per share and sales of $1.49 billion, beating analyst consensus estimates. The company estimates full-year revenue growth between 14% and 15%, and earnings per share growth between 24% and 25%. Following the earnings announcement, Keybanc, Baird, and Rosenblatt raised their price targets on Synopsys. The company also announced leadership changes with Sassine Ghazi becoming CEO effective Jan. 1.

Portfolio Pulse from Lisa Levin

August 17, 2023 | 12:55 pm

BILI

CVS

MOOD

Modular Medical partners with Phillips-Medisize to expand insulin delivery alternatives, causing a 45% increase in MOOD's stock. Bilibili's Q2 adjusted EPS of $(0.32) beats the $(0.35) estimate, and sales of $731.50M beat the $726.38M estimate, leading to a 7.8% increase in BILI's stock. Blue Shield of California collaborates with Amazon Pharmacy, Mark Cuban Cost Plus Drug Company, and others, with CVS Caremark providing specialty pharmacy services for members with complex conditions, causing an 8% decrease in CVS's stock.

Portfolio Pulse from ryanfaloona@benzinga.com

August 17, 2023 | 12:47 pm

TPR

Tapestry Inc's executive has projected that the company's Q1 earnings per share will approach $0.90.

Portfolio Pulse from Benzinga Newsdesk

August 17, 2023 | 12:45 pm

CPRI

TPR

Tapestry Inc (NYSE:TPR) reported Q4 FY23 sales of $1.62 billion, missing the analyst consensus of $1.65 billion. EPS of $0.95 also missed the consensus of $0.97. However, gross profit rose to $1.17 billion from $1.12 billion a year ago. The company also provided a below-consensus outlook for FY24. Last week, Tapestry announced the acquisition of Capri Holdings (NYSE:CPRI) for $8.5 billion, expected to be completed in 2024.

Portfolio Pulse from Lekha Gupta

August 17, 2023 | 12:43 pm

RNXT

RenovoRx (NASDAQ:RNXT) reported Q2 losses of $(0.22) per share, beating the analyst consensus estimate of $(0.25) by 12 percent. This represents a 24.14 percent increase over losses of $(0.29) per share from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 17, 2023 | 12:39 pm

JD

JD.com reported Q2 FY23 revenue growth of 7.6% YoY to $39.7 billion, beating the consensus of $38.7 billion. Non-GAAP net income per ADS of $0.74 also beat the consensus of $0.66. Despite the positive results, JD.com shares fell 3% to close at $34.88 on Wednesday but added 2% in today's pre-market trading session. B of A Securities and Mizuho lowered their price targets on JD.com following the earnings announcement.

Portfolio Pulse from Lisa Levin

August 17, 2023 | 12:31 pm